Tacrolimus and the Risk of Solid Cancers After Liver Transplant: A Dose Effect Relationship

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|15|3|678-686

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.3, 2015-03, pp. : 678-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1748-1755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 8, 2015-08 ,pp. : 667-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997–2010

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 841-848

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to: lower‐dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 625-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved Survival in Liver Transplant Recipients Receiving Prolonged‐Release Tacrolimus in the European Liver Transplant Registry

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1267-1282

John Wiley & Sons Inc

Access to resources Recommend Favorite